Martina B, Weinbacher M, Drewe J, Gasser P
Medical Outpatient Clinic, University Hospital, Basel, Switzerland.
J Hum Hypertens. 1998 Jul;12(7):473-8. doi: 10.1038/sj.jhh.1000647.
To measure the effects of losartan and amlodipine on peripheral capillary microcirculation in hypertension.
Medical out-patient clinic, Basel, in a university teaching hospital.
After a 4-week placebo run-in period 20 patients aged 50 +/- 8 (range 36-65) years with mild-to-moderate hypertension were randomly allocated to receive active treatment with losartan 50 mg titrated to losartan 50 mg/hydrochlorothiazide (HCT) 12.5 mg, or amlodipine 5 mg titrated to 10 mg for a 12 week period. Titration was performed if diastolic blood pressure (BP) was > or=90 mm Hg after 6 weeks of treatment. BP measurements as well as video capillary microscopy of the finger nailfold at the end of the placebo period and after 12 weeks of active treatment were compared. Capillary blood cell velocity was measured at rest and immediately, 1 min and 2 min after local finger cooling.
After 3 months of treatment with amlodipine (n = 10) and losartan titrated to losartan-HCT (n = 10) sitting BP decreased significantly from 160 +/- 7/103 +/- 4 mm Hg and 147 +/- 7/98 +/- 6 mm Hg to 131 +/- 10/86 +/- 7 mm Hg and 134 +/- 17/89 +/- 9 mm Hg, respectively (P < 0.01). After local finger cooling the area under the curve (AUC) of capillary blood cell velocities was 1.13 +/- 0.58 mm (median +/- s.d.) at baseline and increased to 1.94 +/- 1.15 (P < 0.05) in losartan/losartan-HCT treated patients. In amlodipine treated patients the increase in AUC of capillary blood cell velocity did not reach the level of statistical significance (1.59 +/- 1.36 to 2.14 +/- 1.05 mm).
This small trial shows that the area under the curve of capillary blood cell velocity increases in hypertensive patients treated with both losartan/losartan-HCT and amlodipine compared with baseline values.
测定氯沙坦和氨氯地平对高血压患者外周毛细血管微循环的影响。
巴塞尔一所大学教学医院的门诊。
经过4周的安慰剂导入期后,20名年龄在50±8(范围36 - 65)岁的轻度至中度高血压患者被随机分配接受氯沙坦50 mg滴定至氯沙坦50 mg/氢氯噻嗪(HCT)12.5 mg的积极治疗,或氨氯地平5 mg滴定至10 mg,为期12周。如果治疗6周后舒张压(BP)≥90 mmHg,则进行滴定。比较安慰剂期结束时和积极治疗12周后的血压测量值以及指甲襞的视频毛细血管显微镜检查结果。在静息状态下以及局部手指冷却后即刻、1分钟和2分钟测量毛细血管血细胞速度。
用氨氯地平治疗3个月后(n = 10)以及滴定至氯沙坦 - HCT的氯沙坦治疗后(n = 10),坐位血压分别从160±7/103±4 mmHg和147±7/98±6 mmHg显著降至131±10/86±7 mmHg和134±17/89±9 mmHg(P < 0.01)。局部手指冷却后,氯沙坦/氯沙坦 - HCT治疗的患者基线时毛细血管血细胞速度曲线下面积(AUC)为1.13±0.58 mm(中位数±标准差),并增加至1.94±1.15(P < 0.05)。氨氯地平治疗的患者中,毛细血管血细胞速度AUC的增加未达到统计学显著水平(从1.59±1.36至2.14±1.05 mm)。
这项小型试验表明,与基线值相比,氯沙坦/氯沙坦 - HCT和氨氯地平治疗的高血压患者毛细血管血细胞速度曲线下面积增加。